Phibro Animal Health (PAHC) EBITDA (2012 - 2026)

Phibro Animal Health's EBITDA history runs 15 years deep, the most recent figure standing at $44.7 million for Q1 2026.

• In Q1 2026, EBITDA rose 33.23% year-over-year to $44.7 million; the TTM figure through Mar 2026 stood at $134.0 million (up 160.44% YoY), while the FY2025 annual figure was $110.5 million, up 107.19% from the prior year.
• EBITDA was $44.7 million for Q1 2026 at Phibro Animal Health, up from $25.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $44.7 million in Q1 2026 to a low of -$7.0 million in Q4 2024.
• Historically, EBITDA has averaged $17.8 million across 5 years, with a median of $19.2 million in 2022.
• The sharpest annual moves came in 2022 and 2024: EBITDA soared 1521.43% in 2022, then slumped 380.12% in 2024.
• A 5-year view of EBITDA shows it stood at $10.5 million in 2022, then sank by 75.99% to $2.5 million in 2023, then plunged by 380.12% to -$7.0 million in 2024, then soared by 456.42% to $25.1 million in 2025, then soared by 77.83% to $44.7 million in 2026.
• The last three EBITDA figures came in at $44.7 million (Q1 2026), $25.1 million (Q4 2025), and $30.5 million (Q3 2025), per Business Quant data.